Rapamycin causes regression of astrocytomas in tuberous sclerosis complex - Test2 - elhamkhani - TriplyDB

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

http://www.wikidata.org/entity/Q28295149

about

Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options Rapamycin and its analogues (rapalogs) for tuberous sclerosis complex Subependymal Giant Cell Astrocytoma (SEGA) Treatment Update The tuberous sclerosis complex Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy The TSC1-TSC2 complex: a molecular switchboard controlling cell growth Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas Rapamycin and rapalogs for tuberous sclerosis complex Neuroimaging in pediatric phakomatoses. An educational review.Rapamycin and its analogues (rapalogs) for Tuberous Sclerosis Complex-associated tumors: a systematic review on non-randomized studies using meta-analysis The neurology of mTOR Amino acids and mTORC1: from lysosomes to disease Pathological and molecular advances in pediatric low-grade astrocytoma Stochastic model of Tsc1 lesions in mouse brain Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57BL/6 mice Hereditary genodermatoses with cancer predisposition Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits Mechanism-based treatment in tuberous sclerosis complex.Efficacy and safety of Everolimus in children with TSC - associated epilepsy - Pilot data from an open single-center prospective study.Clinical presentation and diagnosis of tuberous sclerosis complex in infancy.Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population.Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779 Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model.Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models Pediatric low-grade gliomas and the need for new options for therapy: Why and how?Effects of Rapamycin on Clinical Manifestations and Blood Lipid Parameters in Different Preeclampsia-like Mouse Models Curing epilepsy: progress and future directions Subependymal Giant Cell Astrocytoma Presenting with Tumoral Bleeding: A Case Report.The PIK3CA gene as a mutated target for cancer therapy.Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors mTORC1 activation in childhood ependymoma and response to sirolimus.From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis.Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway.

P2860

Q22305852-602E7D23-8379-4C9E-9A0A-C1E7360C3E62 Q24194140-5E8D5AB7-52E3-45A0-85F5-9FCEAF4EA501 Q24597688-C149508B-0651-4779-B23B-AAB8BE67EBC1 Q24628011-EF3946DF-3417-44CA-ABE6-437A801B547E Q24628724-1446E372-7616-42C7-A54B-E4AD9FD31298 Q24645204-4E3D01F0-32DE-4E7D-BD43-5A64B55EB0A5 Q24658269-0013C8B0-ED5E-45B9-85F5-DA37175B72F2 Q26471128-5C45A73C-7307-4205-8493-F0AE38F3379F Q26752705-78604AB4-9FEE-44D7-AA87-C971AC6FCEF4 Q26799757-04FAB785-F536-4F02-B5D5-30D02CE96393 Q26824286-A5744E9F-7DA5-4229-81FC-55EA3B0D0D07 Q27009377-B06ECA69-3A18-434D-A247-3E76DA2371E5 Q27026123-F6D1E9CE-8799-4E90-9B5E-A36C3B39D1B5 Q27319406-6099701B-0D9D-44A2-A9AA-4F22D03B2A11 Q28481010-DA08FB0E-C133-43C4-AB88-25151EF74764 Q28487708-342281D1-9EE8-4E01-9F2A-5C27089C6377 Q29618030-90F3F3B8-A487-4561-B700-1EE849E80DEF Q30444988-19E18F21-CDAD-4916-B16A-2B380B87655C Q30470596-7D1BB6F8-92D8-4075-845C-CBD67EE96AF5 Q30541746-03CAE3E8-E186-46E7-B241-2AB186931980 Q30573030-673035CC-FB69-4DF4-AA25-E5C26C497B5D Q30597707-570DE165-85FD-425D-BED9-2BEB3F8A2F2A Q30746587-9A106F91-AB28-4D45-9AE3-E93DA8C4AE97 Q31140724-C2493B63-0746-4409-B648-2FE9B36270F3 Q31144575-CF3B4CC1-6FFB-4DEA-BED7-952AD2C40880 Q33274047-8ED869DA-8300-445F-B1BB-34F3240EFAB7 Q33305157-E29B03D5-92B4-49D5-8C58-6C42F438EBEE Q33316872-7B3200A6-1148-4990-9E70-D0B7A91D0939 Q33403043-CA526C93-507A-438F-96A3-BCF36AD1F01F Q33430534-7E0641F2-8820-45AD-9ED8-0C18859A729B Q33607387-808AC7B8-CCC7-4B3C-A9D8-886781834DC7 Q33646644-B815055C-9085-4122-AAC0-2FBAE9DC67A6 Q33655266-8F3EA653-4A2C-45D9-9412-A04D0364A9CB Q33694246-591AB50A-A3BC-4563-9493-2A8FAB2F0CCF Q33699378-E9B71329-7F71-4E7D-9E45-C63A3133AF4A Q33711691-950F5DC9-2777-4BC2-AEFF-51B2ABAFA1C6 Q33746501-750977D3-68CA-49E0-879F-F5452DCE7EAF Q33750454-47DFF2E0-DE67-4686-AF21-991A94C46282 Q33757948-FFF54B3A-7666-42B1-BB33-919972E71A99 Q33805859-D729A49F-F8D4-4745-BB7B-E92E0CFC0D77

P2860

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

http://www.wikidata.org/entity/Q28295149

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

@ast

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

@en

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

@nl

type

label

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

@ast

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

@en

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

@nl

prefLabel

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

@ast

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

@en

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

@nl

P1433

Q28295149-2EBE290B-17AC-4D06-A834-9118EE13EB87

P1476

Q28295149-6CE80493-AA6A-470C-B64F-58CB698AE3AC

P2093

Q28295149-0231C053-2821-455A-996F-A6096505ADB8

Q28295149-17DE5B16-3575-45A2-9236-3F21973FBCBA

Q28295149-36A2176F-EC5E-487B-A59A-4E0AABB24A9A

Q28295149-85F87297-78EC-46AC-BEFD-4C6D8B8AEFC2

Q28295149-A67337D7-E8DF-42A3-990F-A068FE14928C

Q28295149-BF53DF30-7746-4788-BD3C-80C3371BF55E

Q28295149-CD81F28A-FA90-4EC1-9B25-503A4B8764AB

Q28295149-EB9BC4A9-6F9B-45E7-8A8D-F6EF1F2BC6D2

P2860

Q28295149-87633BAE-E790-4D19-86E8-3BA800CE268F

P304

Q28295149-E90C600D-3B12-4B67-918F-440DB71D3FA8

P31

Q28295149-ADD4C6BE-0F60-43F3-B115-5AF9ADB81595

P3181

Q28295149-1FEEE222-1991-46F3-B8FE-9F1EB7EAB865

P356

Q28295149-62626F85-3A4E-4877-BFBA-9153409DBF46

P407

Q28295149-8659647D-FA61-4F98-9345-AC80E0ACF64C

P433

Q28295149-B46DB344-F531-4243-8E04-5C724619346B

P478

Q28295149-E284E91F-0929-4979-A265-D2267293DC78

P50

Q28295149-C0B1D0C5-78B3-4527-8FAF-31C682F92BBE

P577

Q28295149-4F4CB884-66D3-4BBB-AAED-ACA1F5CD039B

P698

Q28295149-97486CBF-E0EA-4800-B601-F2569A952754

P3181

P356

P1433

Annals of Neurology

P1476

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

@en

P2093

Argirios Dinopoulos

http://www.w3.org/2001/XMLSchema#string

Cynthia Tudor

http://www.w3.org/2001/XMLSchema#string

David Neal Franz

http://www.w3.org/2001/XMLSchema#string

Gail Chuck

http://www.w3.org/2001/XMLSchema#string

Gopalan Sethuraman

http://www.w3.org/2001/XMLSchema#string

Jennifer Leonard

http://www.w3.org/2001/XMLSchema#string

Kerry R Crone

http://www.w3.org/2001/XMLSchema#string

Marguerite Care

http://www.w3.org/2001/XMLSchema#string

P2860

Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis.

P304

490-498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1100474

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ANA.20784

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16453317

http://www.w3.org/2001/XMLSchema#string